TerminatedPhase 4NCT01898806

Intralesional Steroids in the Treatment of Alopecia Areata

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Columbia University
Principal Investigator
Julian Mackay-Wiggan, MD, MS, M.D
Columbia University
Intervention
Intralesional Triamcinolone 2.5 mg/ml(drug)
Enrollment
11 target
Eligibility
18-75 years · All sexes
Timeline
20112018

Study locations (2)

Collaborators

University of Minnesota

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01898806 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials